KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Equity Average (2016 - 2025)

AbbVie (ABBV) has disclosed Equity Average for 13 consecutive years, with -$2.9 billion as the latest value for Q4 2025.

  • Quarterly Equity Average fell 162.47% to -$2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.9 billion through Dec 2025, down 162.47% year-over-year, with the annual reading at $48.5 million for FY2025, 99.29% down from the prior year.
  • Equity Average for Q4 2025 was -$2.9 billion at AbbVie, down from -$1.4 billion in the prior quarter.
  • The five-year high for Equity Average was $16.7 billion in Q4 2022, with the low at -$2.9 billion in Q4 2025.
  • Average Equity Average over 5 years is $9.8 billion, with a median of $12.8 billion recorded in 2021.
  • The sharpest move saw Equity Average skyrocketed 272.13% in 2021, then crashed 162.47% in 2025.
  • Over 5 years, Equity Average stood at $14.5 billion in 2021, then increased by 14.82% to $16.7 billion in 2022, then plummeted by 32.38% to $11.3 billion in 2023, then plummeted by 58.29% to $4.7 billion in 2024, then plummeted by 162.47% to -$2.9 billion in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at -$2.9 billion, -$1.4 billion, and $662.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.